CN109628592B - 甲状腺癌相关标志物及其应用 - Google Patents
甲状腺癌相关标志物及其应用 Download PDFInfo
- Publication number
- CN109628592B CN109628592B CN201811572086.XA CN201811572086A CN109628592B CN 109628592 B CN109628592 B CN 109628592B CN 201811572086 A CN201811572086 A CN 201811572086A CN 109628592 B CN109628592 B CN 109628592B
- Authority
- CN
- China
- Prior art keywords
- linc02560
- ggtlc3
- thyroid cancer
- sirna
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
组分 | 加入量 |
2×mix | 10μL |
上游引物(10μM) | 0.5μL |
下游引物(10μM) | 0.5μL |
模板 | 2μL |
加入灭菌蒸馏水 | 至25μL |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811572086.XA CN109628592B (zh) | 2018-12-21 | 2018-12-21 | 甲状腺癌相关标志物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811572086.XA CN109628592B (zh) | 2018-12-21 | 2018-12-21 | 甲状腺癌相关标志物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109628592A CN109628592A (zh) | 2019-04-16 |
CN109628592B true CN109628592B (zh) | 2022-04-12 |
Family
ID=66076192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811572086.XA Active CN109628592B (zh) | 2018-12-21 | 2018-12-21 | 甲状腺癌相关标志物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109628592B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014022594A1 (en) * | 2012-07-31 | 2014-02-06 | Daniel Mercola | Stroma biomarkers for prostate cancer prognosis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090105167A1 (en) * | 2007-10-19 | 2009-04-23 | Duke University | Predicting responsiveness to cancer therapeutics |
-
2018
- 2018-12-21 CN CN201811572086.XA patent/CN109628592B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014022594A1 (en) * | 2012-07-31 | 2014-02-06 | Daniel Mercola | Stroma biomarkers for prostate cancer prognosis |
Non-Patent Citations (3)
Title |
---|
Gamma-Glutamyl Transpeptidase: Redox Regulation and Drug Resistance;Marie H. Hanigan;《Adv Cancer Res.》;20141231;第103-141页 * |
Rapid detection of papillary thyroid carcinoma by fluorescence imaging using a γ-glutamyltranspeptidase-specific probe: a pilot study;Rumi Hino等;《Thyroid Research》;20181130;第1-9页 * |
长链非编码RNA 在甲状腺乳头状癌中的研究进展;蒋烈浩等;《中国肿瘤》;20181130;第851-856页 * |
Also Published As
Publication number | Publication date |
---|---|
CN109628592A (zh) | 2019-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3500307B1 (en) | Use of vcp inhibitor and oncolytic virus in the preparation of an anti-tumor drug | |
CN113462780B (zh) | 一种用于前列腺癌辅助诊断的标志物及试剂盒 | |
CN108277279B (zh) | 一种lncRNA在诊断和/或治疗乳腺癌中的应用 | |
Mirna et al. | A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis | |
US20140045924A1 (en) | Melanoma treatments | |
CN107519193A (zh) | 食管鳞癌早期分子诊断标志物及其应用 | |
CN110408703A (zh) | 结直肠癌miRNA标志物及其应用 | |
CN111647660B (zh) | Linc01559在胃癌诊断及治疗中的应用 | |
CN107475386A (zh) | 用于诊治骨肉瘤的长链非编码rna标志物 | |
CN110964831A (zh) | 一种用于检测黑色素瘤的长非编码rna及其应用 | |
CN109628592B (zh) | 甲状腺癌相关标志物及其应用 | |
CN110923324A (zh) | 一种乳腺癌miRNA标记物及其应用 | |
CN107619869B (zh) | 胶质瘤诊断及预后标志物circ16:85633914|85634132及应用 | |
CN115252599A (zh) | 甘草查尔酮a及光甘草定和甘草查尔酮a的组合物在制备治疗结直肠癌的药物中的应用 | |
CN111020036B (zh) | 人circ-STXBP5L的用途及相关产品 | |
CN114164278A (zh) | 一种用于胃癌辅助诊断的标志物及试剂盒 | |
CN109224076B (zh) | 与肺癌诊疗相关的基因miR-140-3P及其mimics和应用 | |
JP2012532149A (ja) | 肺がん予後および薬物調製における2つのマイクロRNAsの使用 | |
KR101828681B1 (ko) | 페리오스틴 압타머를 포함하는 섬유증 진단 또는 치료용 조성물 | |
CN107653319B (zh) | 胶质瘤诊断标志物circ8:61680968|61684188及应用 | |
CN110946872B (zh) | miR-4491在制备治疗乳腺癌的药物中的应用 | |
CN114085832B (zh) | 用于抑制PRR14基因的siRNA分子 | |
CN114917217B (zh) | 磷酸二酯酶4抑制剂ZL-n-91在制备治疗三阴性乳腺癌的药物中的应用 | |
CN111455054B (zh) | 放射性癌的诊断和治疗用分子 | |
CN111808954B (zh) | lncRNA及其在疾病中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Dong Inventor after: Xiong Hui Inventor after: Yao Guangyin Inventor after: Li Li Inventor after: Ji Zhili Inventor after: Yang Longyan Inventor after: Sun Rongxin Inventor before: Zhao Dong Inventor before: Xiong Hui Inventor before: Yao Guangyin Inventor before: Li Li Inventor before: Ji Zhili Inventor before: Yang Longyan Inventor before: Sun Rongxin |
|
GR01 | Patent grant | ||
GR01 | Patent grant |